Gastric Insufflation and Laryngeal Mask Airway

Not Applicable

• Conditions: Gastric Insufflation
• Interventions: Device: AuraOnceTM; Device: LMA SupremeTM

• Registration Number: NCT02097771
• Lead Sponsor: Lionel Bouvet

Brief Summary

Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-03-21
• Study First Submitted QC: 2014-03-24
• Study First Posted: 2014-03-27
• Status Verified: 2014-11
• Study Start: 2014-11
• Last Update Submitted: 2014-11-18
• Last Update Posted: 2014-11-19
• Primary Completion: 2015-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• ASA 1 or 2
• Age > 18 yrs
• Use of laryngeal mask airway required

Exclusion Criteria

• risk of pulmonary aspiration of gastric contents
• Contraindication for the use of laryngeal mask airway
• Tracheal intubation required
• Patient's refusal

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Ambu AuraOnce	AuraOnceTM	-
LMA SupremeTM	LMA SupremeTM	-

Primary Outcome Measures

Name	Time	Method
incidence of gastric insufflation	during pulmonary ventilation through the laryngeal mask airway

Trial Locations

Locations (1)

Hospices Civils de Lyon; 🇫🇷 Lyon, France